Reports first surfaced in 2005 that the radial arms and struts of medical equipment manufacturer Bard’s Recovery IVC Filter had broken off inside the body of patients. Since that time the U.S. Food and Drug Administration (FDA) has received around 1000 adverse reports involving the filters, primarily regarding the IVC filters fragmenting and embolizing inside the body.
Due to these reports, made by both physicians and patients, and extensive research of the filters, the FDA urged physicians to consider the risks before recommending the IVC Filter be installed in patients who are ineligible for anticoagulation therapy. The FDA also recommends that the filters be removed as soon as the risk of Pulmonary Embolism has passed.
Despite the FDA’s warning, Bard’s redesigned IVC Filter has been implanted in more than 65,000 patients.
Since the IVC Filter was introduced in 2005, the FDA has received close to 1000 adverse reports relating to the devices. These reports involved:
- 328 Device Migrations
- 146 Embolizations/Detachment of the Device Components
- 70 IVC Perforations
- 56 IVC Filter Fractures
- Fracture of the IVC Filter
- IVC Filter Migration
- Perforation, Puncture or Serious Damage to the Heart, Lungs or Vena Cava
- Internal Bleeding
- Cardiac or Pericardial Tamponade
- Ventricle Tachycardia
- Lower Limb DVT
- Hematoma or Nerve Injury at the Puncture Site
- Constant and Severe Pain in the Heart, Chest or Elsewhere in the Body
- Pulmonary Embolism
- Respiratory Distress
- Shortness of Breath
- Other Serious Injury and Death
Please use the form on this page or contact our IVC Filter Lawyers today at 1-888-352-4850.